Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Lichen planus may be associated with a higher risk of metabolic syndrome.

Effective treatments for scalp psoriasis include glucocorticosteroids, Vitamin D3 analogs, and combination therapies like calcipotriol and betamethasone dipropionate.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Polygenic Score can help predict severe psoriasis and psoriatic arthritis.

Polyglutamic acid is a valuable, sustainable ingredient for skincare and haircare products.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

The new bariatric surgery SAGI PGP is effective for weight loss and diabetes control with few complications.

A new tool simplifies alopecia areata severity scoring but needs validation.

New grading scale accurately measures hair loss severity and treatment effectiveness.

PGD2 stops hair growth and is higher in bald men with AGA.

PSA can help diagnose high androgen levels in women.

The solution increased hair density safely and effectively for hair loss.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Generative AI tools can accurately score alopecia areata, reducing subjectivity in evaluations.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

The FG score is better at detecting hyperandrogenism in PCOS patients than testosterone levels or FAI, but testosterone is the recommended test for diagnosis.

Scalp coverage scoring accurately measures hair loss and treatment effectiveness.

Microneedle-delivered polyglutamate effectively and safely improves hair growth in androgenetic alopecia.

No link between hair loss severity and PSA levels in men.

The new system helps detect and track early female hair loss better.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

The SGAP flap effectively treats large sacral pressure sores with good results and minimal complications.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Ultra-high molecular weight poly-γ-glutamic acid may help promote hair growth.